{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:46:56Z","timestamp":1788871616034,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Division of Instrumental Analysis of the Research Center for Human and Environmental Sciences"}],"content-domain":{"domain":["brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.braindev.2014.12.007","type":"journal-article","created":{"date-parts":[[2015,1,3]],"date-time":"2015-01-03T16:52:03Z","timestamp":1420303923000},"page":"808-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis"],"prefix":"10.1016","volume":"37","author":[{"given":"Takafumi","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2014.12.007_b0005","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2014.12.007_b0010","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.41.8.1270","article-title":"Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients","volume":"41","author":"Sommer","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2014.12.007_b0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.braindev.2014.12.007_b0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0035","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/eji.200737973","article-title":"CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity","volume":"38","author":"Bai","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0040","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.braindev.2014.12.007_b0045","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.braindev.2014.12.007_b0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2003.10.004","article-title":"A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan","volume":"110","author":"Shinomiya","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/mus.21195","article-title":"Juvenile myasthenia gravis","volume":"39","author":"Chiang","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.braindev.2014.12.007_b0060","first-page":"404101","article-title":"Juvenile myasthenia gravis: a paediatric perspective","volume":"2011","author":"Finnis","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.braindev.2014.12.007_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2014.12.007_b0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10875-012-9685-0","article-title":"Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants","volume":"32","author":"Xu","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0075","first-page":"1951","article-title":"Coexistence of Th1\/Th2 and Th17\/Treg imbalances in patients with allergic asthma","volume":"124","author":"Shi","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.braindev.2014.12.007_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-1759(93)90158-4","article-title":"Detection of intracellular cytokines by flow cytometry","volume":"159","author":"Jung","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.braindev.2014.12.007_b0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/\u2212) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2005.03.011","article-title":"Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma","volume":"164","author":"Luther","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0095","first-page":"54","article-title":"Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study","volume":"19","author":"Battaglia","year":"2005","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.braindev.2014.12.007_b0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.braindev.2014.12.007_b0105","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.4049\/jimmunol.180.4.2132","article-title":"Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis","volume":"180","author":"Aricha","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0115","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/WNL.0b013e3181d31e47","article-title":"Undiminished regulatory T cells in the thymus of patients with myasthenia gravis","volume":"74","author":"Matsui","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2014.12.007_b0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.braindev.2010.08.002","article-title":"CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis","volume":"33","author":"Sakuma","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2014.12.007_b0125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.braindev.2014.12.007_b0130","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/eji.200939792","article-title":"Expansion of regulatory T cells via IL-2\/anti-IL-2 mAb complexes suppresses experimental myasthenia","volume":"40","author":"Liu","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0135","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.4049\/jimmunol.0901091","article-title":"Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells","volume":"183","author":"Grindebacke","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jneuroim.2007.04.021","article-title":"A study of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire","volume":"187","author":"Dokai","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.braindev.2014.12.007_b0190","first-page":"585","article-title":"A patient with a relapse of myasthenia gravis after a 13-year remission following successful treatment by mediastinal irradiation and corticosteroid therapy","volume":"47","author":"Yahikozawa","year":"1995","journal-title":"No to shinkei=Brain Nerve (Tokyo)"},{"key":"10.1016\/j.braindev.2014.12.007_b0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/WNL.31.2.220","article-title":"No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis","volume":"31","author":"Roses","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2014.12.007_b0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10059-009-0114-z","article-title":"Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells","volume":"28","author":"Kogina","year":"2009","journal-title":"Mol Cells"},{"key":"10.1016\/j.braindev.2014.12.007_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.braindev.2014.12.007_b0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.mehy.2010.09.011","article-title":"Bidirectional immunoregulation of calcineurin inhibitor tacrolimus on FOXP3 transcription?","volume":"76","author":"Shen","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.braindev.2014.12.007_b0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2010.09.033","article-title":"Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis","volume":"300","author":"Minami","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2014.12.007_b0180","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"Mu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.braindev.2014.12.007_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand J Immunol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760414002927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760414002927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T06:14:11Z","timestamp":1690784051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760414002927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0387760414002927"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2014.12.007","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}